Doelmatig gebruik van antiretrovirale therapie
- Universiteit Radboud UMC Nijmegen
- Promovendus Msc Piter Oosterhof
- Promoters Prof.dr. David Burger Kees Brinkman
- Co-Promoters ds Matthijs van Luin
- Jaar 2019 - 2023
Research directed at melanoma en lung cancer registries
The landscape of drug development as well as clinical practice has been changing over the last decennium, with the increasing availability and use of biobased therapies. This research is now focusing on the use and therapeutic drug monitoring of biobased factor VIII therapies in hemophilia A patients.
The aim of this project is to provide insight in the use of biologicals, including biosimilars, in clinical practice and add to the safe and effective use of these agents. We also provide guidance on the implementation of biosimilars in clinical practice from the perspective of different stakeholders including prescribers, pharmacists and patients.
Onderzoek gericht op effectieve interventies in detectie en reductie van drug-related problems (DRPs) bij kwetsbare ouderen in tweedelijnszorg. Centraal staat de vraag hoe implementatie van screening tools kan bijdragen aan effectieve zorg op de juiste plaats (targeted pharmaceutical care). Onderdeel hiervan is de ontwikkeling en effectiviteitsevaluatie van een clinical decision support tool in de optimalisatie van farmacotherapie bij ouderen.
Assessment of saliva/plasma ratio for drugs administered to (premature) neonates.